Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Biological Drug Products (eBook)

Development and Strategies

Manmohan Singh, Wei Wang (Herausgeber)

eBook Download: EPUB
2013 | 1. Auflage
744 Seiten
Wiley (Verlag)
978-1-118-69522-7 (ISBN)

Lese- und Medienproben

Biological Drug Products -
Systemvoraussetzungen
167,99 inkl. MwSt
(CHF 164,10)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Tested and proven solutions to the challenges of biological drug product development Biological drug products play a central role in combating human diseases; however, developing new successful biological drugs presents many challenges, including labor intensive production processes, tighter regulatory controls, and increased market competition. This book reviews the current state of the science, offering readers a single resource that sets forth the fundamentals as well as tested and proven development strategies for biological drugs. Moreover, the book prepares readers for the challenges that typically arise during drug development, offering straightforward solutions to improve their ability to pass through all the regulatory hurdles and deliver new drug products to the market. Biological Drug Products begins with general considerations for the development of any biological drug product and then explores the strategies and challenges involved in the development of specific types of biologics. Divided into five parts, the book examines: Part 1: General Aspects Part 2: Proteins and Peptides Part 3: Vaccines Part 4: Novel Biologics Part 5: Product Administration/Delivery Each chapter has been prepared by one or more leading experts in biological drug development. Contributions are based on a comprehensive review and analysis of the current literature as well as the authors' first-hand experience developing and testing new drugs. References at the end of each chapter serve as a gateway to original research papers and reviews in the field. By incorporating lessons learned and future directions for research, Biological Drug Products enables pharmaceutical scientists and students to improve their success rate in developing new biologics to treat a broad range of human diseases.

WEI WANG, PhD, is a Research Fellow for Pfizer BioTherapeutics Pharmaceutical Sciences. In addition, Dr. Wang is Adjunct Professor in the School of Pharmacy and Health Sciences at the University of the Pacific. MANMOHAN SINGH, PhD, is Head of Technical Development at Novartis Vaccines and Diagnostics. Dr. Singh has authored over 120 peer-reviewed manuscripts, reviews, and book chapters in the area of vaccine formulations and adjuvant research. He is also an Adjunct Professor at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill.

Dedication

Preface

Part 1. General Aspects 1

Chapter 1. An Overview of Discovery and Development Process For
Biologics 3

Heather H. Shih, Paula Miller and Douglas C. Harnish

Chapter 2. Nonclinical Safety Assessment of Biologics, Including
Vaccines 31

Liangbiao George Hu, David W. Clarke

Chapter 3 Clinical Assessment of Biologics Agents 57

Lesley Ann Saketkoo, Shikha Mittoo and Luis R. Espinoza

Chapter 4. Key Regulatory Guidelines for Development of
Biologics In The U.S. And Europe 75

Richard Kingham, Gabriela Klasa and Krista Hessler
Carver

Chapter 5. Landscape and Consideration of Intellectual Property
for Development Of Biosimilars 111

Srikumaran Melethil

Chapter 6. Scientific Aspects of Sterility Assurance, Sterility,
Asepsis, and Sterilization 133

James E. Akers and James P. Agalloco

Part 2. Proteins/Peptides 163

Chapter 7. Cell Cell Culture Processes in Monoclonal Antibody
Production 165

Feng Li, Amy (Yijuan) Shen and Ashraf Amanullah

Chapter 8. Protein/Peptide Purification and Virus Reduction
203

Beckley K. Nfor, Esteban Freydell and Marcel Ottens

Chapter 9. Chemical and Genetic Modification 233

M Farys, C Ginn, G Badescu, K Peciak, E Pawlisz, H Khalili and S
Brocchini

Chapter 10. Analytical Characterization of Proteins/Peptides
285

Yajun Jennifer Wang and Brian Hosken

Chapter 11. Protein/Peptide Formulation Development 323

Satoshi Ohtake and Wei Wang

Chapter 12. Regulatory Strategies and Lessons in the Development
Of Biosimilars 367

Umang S. Shah

Part 3. Vaccines 409

Chapter 13. Vaccine Development - History, Current Status
and Future Trends 411

Leo Van Der Pol and Jean-Pierre Amorij

Chapter 14. Role and Application of Adjuvants and Delivery
Systems in Vaccines 437

Rajesh K. Gupta

Chapter 15. Methods for Characterizing Proteins in Aluminum
Adjuvant Formulations 469

Martinus A.H. Capelle, Emilie Poirier and Tudor Arvinte

Part 4. Novel Biologics 487

Chapter 16. The State Of The Art and Future of Gene Medicines
489

Frank Jacobs, Stephanie C. Gordts and Bart De Geest

Chapter 17. Nucleic Acid Vaccines 531

Rachel Buglione-Corbett, John Suschak, Shixia Wang and Shan
Lu

Chapter 18. Multifunctional Polymeric Nano-Systems for Rna
Interference Therapy 569

Arun Iyer, Shanthi Ganesh, Qiong L. Zhou and Mansoor
Amiji

Chapter 19. Advent and Maturation of Regenerative Medicine
601

Abner M. Mhashilkar and Anthony Atala

Part 5. Product Administration/Delivery 629

Chapter 20. Conventional and Novel Container Closure/Delivery
Systems 631

Joseph Wong and Mahesh V. Chaubal

Chapter 21. Controlled-Release Systems for Biologics 655

Mayura Oak, Rhishikesh Mandke, Buddhadev Layek, Gitanjali Sharma
and Jagdish Singh

Chapter 22. Routes of Delivery for Biological Drug Products
677

Darrell J. Irvine, Xingfang Su and Brandon Kwong

INDEX 725

"Thus, it will be a valuable resource for both novice and
expert alike." (ChemMedChem, 1 October 2014)

Erscheint lt. Verlag 29.8.2013
Sprache englisch
Themenwelt Medizin / Pharmazie Gesundheitsfachberufe
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Chemie
Technik
Schlagworte Biowissenschaften • Cell & Molecular Biology • Chemie • Chemistry • Drug Discovery & Development • Life Sciences • Medical Science • Medizin • Pharmacology & Pharmaceutical Medicine • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung • Zell- u. Molekularbiologie
ISBN-10 1-118-69522-4 / 1118695224
ISBN-13 978-1-118-69522-7 / 9781118695227
Haben Sie eine Frage zum Produkt?
EPUBEPUB (Adobe DRM)
Größe: 4,6 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich